First Episealer® surgery in Portugal scheduled

Report this content

Episurf Medical (Nasdaq: EPIS B) today announces that the first Episealer® surgery (Episealer® Knee) in Portugal has been scheduled. The Episealer® Knee and Episealer® Talus implants were recently registered and approved for sale and distribution in Portugal. 

“We are adding yet another country in which the Episealer® implants are used, and I am pleased that our global regulatory strategy results in additional surgeries in more and more countries,” says Pål Ryfors, CEO Episurf Medical.

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: